

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in the management of peptic ulcer... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1763/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1763" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in the management of peptic ulcer bleeding" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in the management of peptic ulcer bleeding.">
            <meta name="og:description" content="Read the latest article version by Ian Beales, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12175">
            <meta name="article-id" content="11286">
            <meta name="dc.title" content="Recent advances in the management of peptic ulcer bleeding">
            <meta name="dc.description" content="Acute upper gastrointestinal haemorrhage due to peptic ulcer bleeding remains an important cause of emergency presentation and hospital admission. Despite advances in many aspects of management, peptic ulcer bleeding is still associated with significant morbidity, mortality, and healthcare costs. Comprehensive international guidelines have been published, but advances as well as controversies continue to evolve. Important recent advances include the evidence supporting a more restrictive transfusion strategy aiming for a target haemoglobin of 70&ndash;90 g/l. Comparative studies have confirmed that the Glasgow&ndash;Blatchford score remains the most useful score for predicting the need for intervention as well as for identifying the lowest-risk patients suitable for outpatient management. New scores, including the AIMS65 and Progetto Nazionale Emorragia Digestiva score, may be more accurate in predicting mortality. Pre-endoscopy erythromycin appears to improve outcomes and is probably underused. High-dose oral proton pump inhibition (PPI) for 11 days after PPI infusion is advantageous in those with a Rockall score of 6 or more. Oral is as effective as parenteral iron at restoring haemoglobin levels after a peptic ulcer bleed and both are superior to placebo in this respect. Within endoscopic techniques, haemostatic powders and over-the-scope clips can be used when other methods have failed. A disposable Doppler probe appears to provide more accurate determination of both rebleeding risk and the success of endoscopic therapy than purely visual guidance. Non- Helicobacter pylori , non-aspirin/non-steroidal anti-inflammatory drug ulcers contribute an increasing percentage of bleeding peptic ulcers and are associated with a poor prognosis and high rebleeding rate. The optimal management of these ulcers remains to be determined.">
            <meta name="dc.subject" content="gastrointestinal hemorrhage, peptic ulcer hemorrhage, endoscopic hemostasis, H pylori, anticoagulant drugs, non-steroidal anti-inflammatory drugs ">
            <meta name="dc.creator" content="Beales, Ian">
            <meta name="dc.date" content="2017/09/27">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11286.1">
            <meta name="dc.source" content="F1000Research 2017 6:1763">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="gastrointestinal hemorrhage">
            <meta name="prism.keyword" content=" peptic ulcer hemorrhage">
            <meta name="prism.keyword" content=" endoscopic hemostasis">
            <meta name="prism.keyword" content=" H pylori">
            <meta name="prism.keyword" content=" anticoagulant drugs">
            <meta name="prism.keyword" content=" non-steroidal anti-inflammatory drugs ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/09/27">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1763">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11286.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1763">
            <meta name="citation_title" content="Recent advances in the management of peptic ulcer bleeding">
            <meta name="citation_abstract" content="Acute upper gastrointestinal haemorrhage due to peptic ulcer bleeding remains an important cause of emergency presentation and hospital admission. Despite advances in many aspects of management, peptic ulcer bleeding is still associated with significant morbidity, mortality, and healthcare costs. Comprehensive international guidelines have been published, but advances as well as controversies continue to evolve. Important recent advances include the evidence supporting a more restrictive transfusion strategy aiming for a target haemoglobin of 70&ndash;90 g/l. Comparative studies have confirmed that the Glasgow&ndash;Blatchford score remains the most useful score for predicting the need for intervention as well as for identifying the lowest-risk patients suitable for outpatient management. New scores, including the AIMS65 and Progetto Nazionale Emorragia Digestiva score, may be more accurate in predicting mortality. Pre-endoscopy erythromycin appears to improve outcomes and is probably underused. High-dose oral proton pump inhibition (PPI) for 11 days after PPI infusion is advantageous in those with a Rockall score of 6 or more. Oral is as effective as parenteral iron at restoring haemoglobin levels after a peptic ulcer bleed and both are superior to placebo in this respect. Within endoscopic techniques, haemostatic powders and over-the-scope clips can be used when other methods have failed. A disposable Doppler probe appears to provide more accurate determination of both rebleeding risk and the success of endoscopic therapy than purely visual guidance. Non- Helicobacter pylori , non-aspirin/non-steroidal anti-inflammatory drug ulcers contribute an increasing percentage of bleeding peptic ulcers and are associated with a poor prognosis and high rebleeding rate. The optimal management of these ulcers remains to be determined.">
            <meta name="citation_description" content="Acute upper gastrointestinal haemorrhage due to peptic ulcer bleeding remains an important cause of emergency presentation and hospital admission. Despite advances in many aspects of management, peptic ulcer bleeding is still associated with significant morbidity, mortality, and healthcare costs. Comprehensive international guidelines have been published, but advances as well as controversies continue to evolve. Important recent advances include the evidence supporting a more restrictive transfusion strategy aiming for a target haemoglobin of 70&ndash;90 g/l. Comparative studies have confirmed that the Glasgow&ndash;Blatchford score remains the most useful score for predicting the need for intervention as well as for identifying the lowest-risk patients suitable for outpatient management. New scores, including the AIMS65 and Progetto Nazionale Emorragia Digestiva score, may be more accurate in predicting mortality. Pre-endoscopy erythromycin appears to improve outcomes and is probably underused. High-dose oral proton pump inhibition (PPI) for 11 days after PPI infusion is advantageous in those with a Rockall score of 6 or more. Oral is as effective as parenteral iron at restoring haemoglobin levels after a peptic ulcer bleed and both are superior to placebo in this respect. Within endoscopic techniques, haemostatic powders and over-the-scope clips can be used when other methods have failed. A disposable Doppler probe appears to provide more accurate determination of both rebleeding risk and the success of endoscopic therapy than purely visual guidance. Non- Helicobacter pylori , non-aspirin/non-steroidal anti-inflammatory drug ulcers contribute an increasing percentage of bleeding peptic ulcers and are associated with a poor prognosis and high rebleeding rate. The optimal management of these ulcers remains to be determined.">
            <meta name="citation_keywords" content="gastrointestinal hemorrhage, peptic ulcer hemorrhage, endoscopic hemostasis, H pylori, anticoagulant drugs, non-steroidal anti-inflammatory drugs ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Ian Beales">
            <meta name="citation_author_institution" content="Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, UK">
            <meta name="citation_publication_date" content="2017/09/27">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1763">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11286.1">
            <meta name="citation_firstpage" content="1763">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1763/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1763.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12175 /> <input type=hidden id=articleId name=articleId value=11286 /> <input type=hidden id=xmlUrl value="/articles/6-1763/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1763-v1.xml"> <input type=hidden id=article_uuid value=1a9460cc-c961-4aac-8e9f-4dc275ed723b /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in the management of peptic ulcer bleeding"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11286.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11286.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1763"
  },
  "headline": "Recent advances in the management of peptic ulcer bleeding",
  "datePublished": "2017-09-27T13:15:45",
  "dateModified": "2017-09-27T13:15:45",
  "author": [
    {
      "@type": "Person",
      "name": "Ian Beales"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Acute upper gastrointestinal haemorrhage due to peptic ulcer bleeding remains an important cause of emergency presentation and hospital admission. Despite advances in many aspects of management, peptic ulcer bleeding is still associated with significant morbidity, mortality, and healthcare costs. Comprehensive international guidelines have been published, but advances as well as controversies continue to evolve. Important recent advances include the evidence supporting a more restrictive transfusion strategy aiming for a target haemoglobin of 70&ndash;90 g/l. Comparative studies have confirmed that the Glasgow&ndash;Blatchford score remains the most useful score for predicting the need for intervention as well as for identifying the lowest-risk patients suitable for outpatient management. New scores, including the AIMS65 and Progetto Nazionale Emorragia Digestiva score, may be more accurate in predicting mortality. Pre-endoscopy erythromycin appears to improve outcomes and is probably underused. High-dose oral proton pump inhibition (PPI) for 11 days after PPI infusion is advantageous in those with a Rockall score of 6 or more. Oral is as effective as parenteral iron at restoring haemoglobin levels after a peptic ulcer bleed and both are superior to placebo in this respect. Within endoscopic techniques, haemostatic powders and over-the-scope clips can be used when other methods have failed. A disposable Doppler probe appears to provide more accurate determination of both rebleeding risk and the success of endoscopic therapy than purely visual guidance. Non-Helicobacter pylori, non-aspirin/non-steroidal anti-inflammatory drug ulcers contribute an increasing percentage of bleeding peptic ulcers and are associated with a poor prognosis and high rebleeding rate. The optimal management of these ulcers remains to be determined."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1763.html",
            "name": "Recent advances in the management of peptic ulcer bleeding"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in the management of peptic ulcer bleeding </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12175 data-id=11286 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11286.1" data-recommended="" data-doi="10.12688/f1000research.11286.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1763/v1/pdf?article_uuid=1a9460cc-c961-4aac-8e9f-4dc275ed723b" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11286-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11286-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11286-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Beales I. Recent advances in the management of peptic ulcer bleeding [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1763 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11286.1" target=_blank>https://doi.org/10.12688/f1000research.11286.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11286-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11286 id=track-article-signin-11286 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11286?target=/articles/6-1763.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12175 /> <input name=articleId type=hidden value=11286 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in the management of peptic ulcer bleeding</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:i.beales@uea.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Ian Beales</span></a><a href="https://orcid.org/0000-0003-1923-3237" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1923-3237</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:i.beales@uea.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Ian Beales</span></a><a href="http://orcid.org/0000-0003-1923-3237" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1923-3237</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 27 Sep 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11286.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, UK<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=26516-26428></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=26515-26429></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Acute upper gastrointestinal haemorrhage due to peptic ulcer bleeding remains an important cause of emergency presentation and hospital admission. Despite advances in many aspects of management, peptic ulcer bleeding is still associated with significant morbidity, mortality, and healthcare costs. Comprehensive international guidelines have been published, but advances as well as controversies continue to evolve. Important recent advances include the evidence supporting a more restrictive transfusion strategy aiming for a target haemoglobin of 70–90 g/l. Comparative studies have confirmed that the Glasgow–Blatchford score remains the most useful score for predicting the need for intervention as well as for identifying the lowest-risk patients suitable for outpatient management. New scores, including the AIMS65 and Progetto Nazionale Emorragia Digestiva score, may be more accurate in predicting mortality. Pre-endoscopy erythromycin appears to improve outcomes and is probably underused. High-dose oral proton pump inhibition (PPI) for 11 days after PPI infusion is advantageous in those with a Rockall score of 6 or more. Oral is as effective as parenteral iron at restoring haemoglobin levels after a peptic ulcer bleed and both are superior to placebo in this respect. Within endoscopic techniques, haemostatic powders and over-the-scope clips can be used when other methods have failed. A disposable Doppler probe appears to provide more accurate determination of both rebleeding risk and the success of endoscopic therapy than purely visual guidance. Non-<i>Helicobacter pylori</i>, non-aspirin/non-steroidal anti-inflammatory drug ulcers contribute an increasing percentage of bleeding peptic ulcers and are associated with a poor prognosis and high rebleeding rate. The optimal management of these ulcers remains to be determined. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> gastrointestinal hemorrhage, peptic ulcer hemorrhage, endoscopic hemostasis, H pylori, anticoagulant drugs, non-steroidal anti-inflammatory drugs </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Ian Beales (<a href="mailto:i.beales@uea.ac.uk">i.beales@uea.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Ian Beales </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The author declares that he has no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Beales I. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Beales I. Recent advances in the management of peptic ulcer bleeding [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1763 (<a href="https://doi.org/10.12688/f1000research.11286.1" target=_blank>https://doi.org/10.12688/f1000research.11286.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 27 Sep 2017, <b>6</b>(F1000 Faculty Rev):1763 (<a href="https://doi.org/10.12688/f1000research.11286.1" target=_blank>https://doi.org/10.12688/f1000research.11286.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 27 Sep 2017, <b>6</b>(F1000 Faculty Rev):1763 (<a href="https://doi.org/10.12688/f1000research.11286.1" target=_blank>https://doi.org/10.12688/f1000research.11286.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d15682e143>Introduction</h2><p class="" id=d15682e146>Acute upper gastrointestinal (GI) haemorrhage remains an important clinical problem. The incidence of non-variceal acute upper GI bleeding in the UK is approximately 85 per 100,000 per year<sup><a href="#ref-1">1</a></sup>. Although the specific mortality associated with acute variceal bleeding is higher<sup><a href="#ref-2">2</a></sup>, peptic ulcer bleeding (PUB) remains the commonest cause of acute GI bleeding overall and significant bleeding requiring transfusion<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. Despite considerable advances in many aspects of the management of PUB, the overall mortality remains significant (approximately 10%), the increasing age and comorbidity of the patients somewhat offsetting the therapeutic advances.</p><p class="" id=d15682e164>There are several evidence-based guidelines to aid the management of PUB<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>, although comprehensive audits have shown that all aspects of management do not always reliably follow guidelines<sup><a href="#ref-3">3</a></sup>. New information is continually becoming available in all aspects of PUB, and in many cases these have not had time to directly inform guideline development. In this review, important recent developments in all aspects of managing PUB are discussed and relevant controversies placed into context to aid the practical management of ulcer bleeding.</p><p class="" id=d15682e178>The management of ulcer bleeding can be divided for convenience into areas of recognition, risk assessment, resuscitation, endoscopic and salvage therapies, and drug therapies in both the peri-bleeding and post-bleeding situations.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15682e184>Recognition</h2><p class="" id=d15682e187>Usually the presentation of acute upper GI bleeding is obvious to the clinician, certainly once the presence of blood in the vomitus or melaena passed rectally is detected. One significant dilemma remains over the likely site of bleeding for profuse, haemodynamically significant fresh rectal bleeding. Is this from a colonic source or very rapid transit from an upper GI source? This has implications for the investigative process. In the United Kingdom, nationwide review of severe GI bleeding, general clinical features, and suspicion in this situation were poorly correlated with the actual site of bleeding<sup><a href="#ref-3">3</a></sup>. The presence of a pulse rate greater than the systolic blood pressure was associated with an upper GI source for fresh rectal bleeding<sup><a href="#ref-3">3</a></sup>, and although further studies examining this index in a prospective way are required, it certainly seems reasonable to perform a gastroscopy initially before lower GI endoscopy in these patients showing that degree of circulatory compromise after appropriate resuscitation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15682e201>Resuscitation</h2><p class="" id=d15682e204>Despite the high prevalence of PUB, there are few data on any specifics of fluid resuscitation in this context. The general clinical principles on restoring circulating fluid volume and adequacy of organ perfusion are employed, although it seems inevitable that there will be individual choice in terms of fluids used and rate given. Obviously, randomised studies in this area are extremely difficult to do and hence the widely cited trial examining blood transfusion strategies was extremely welcome<sup><a href="#ref-6">6</a></sup>, although the limitations inherent in recruiting into such a trial in acute bleeding must always be considered when reviewing the results. In common with an increasing body of data from other critically ill patients, across the spectrum of medicine including major sepsis<sup><a href="#ref-7">7</a>,<a href="#ref-8">8</a></sup>, a restrictive blood transfusion strategy seems at least as good as a more traditional liberal strategy. In the key trial<sup><a href="#ref-6">6</a></sup>, the strategy of a single unit as required, and repeated as necessary, with a transfusion trigger of 70 g/l to maintain the haemoglobin at 70–90 g/l was as safe and effective as a more traditional haemoglobin target of 90–110 g/l. The trial recruited all comers with upper GI bleeding and was not specifically designed to look at subgroups. Overall mortality was lower in the restrictive transfusion group (5% versus 9%). Those with variceal bleeding or Child’s A or B cirrhosis particularly seemed to benefit from the conservative transfusion strategy with improved mortality and rebleeding rates. In those with PUB, there was less difference between the two strategies, although all important clinical outcomes favoured the restrictive strategy (mortality 3% versus 5%, rebleeding 10% versus 17%, and surgery 2% versus 6%). Recruitment to the trial was rather selective, excluding those with very severe bleeding and significant circulatory diseases, which may limit generalisation. Data published only in abstract form<sup><a href="#ref-9">9</a></sup> examining real-world outcomes after transfusion for PUB suggested a contrary finding and showed an association between more units transfused and lower death rates.</p><p class="" id=d15682e226>A meta-analysis pooled the results from the four available studies of transfusion strategies in acute upper GI bleeding, although all have different methodologies and inclusion criteria<sup><a href="#ref-10">10</a></sup>. Not all of these included studies specifically examined only acutely bleeding peptic ulceration. Again, results favoured a restrictive strategy: there were significant reductions in death and length of stay with the restrictive strategy. Rebleeding rates were also non-significantly lower in the restrictive group (odds ratio 0.26, 95% confidence interval [CI] 0.03–2.10). An even more recent meta-analysis including only data on acute GI bleeding from five randomised controlled trials showed that a restrictive transfusion strategy was associated with lower all-cause mortality (relative risk 0.65, 95% CI 0.44–0.97) and rebleeding (relative risk 0.58, 95% CI 0.40–0.84) without any effect on ischaemic events<sup><a href="#ref-11">11</a></sup>. The exact optimal resuscitation strategy is unclear and always needs to be individualised to the specific patient. However, given the consistency and biological plausibility of the results and the costs and potential harm of blood transfusion, it would seem prudent to employ a conservative transfusion strategy for most patients with PUB, whilst maintaining adequate circulating fluid volumes.</p><p class="" id=d15682e237>It is important to stress that transfusion strategies are but one part of fluid resuscitation in PUB and that in the acutely bleeding patient haemoglobin levels form only one part of the assessment of cardiovascular instability and that decisions on fluid and blood replacement must be governed by the need to restore adequate organ perfusion. However, it does seem that crystalloid fluid resuscitation followed by blood to maintain the haemoglobin level at 70–90 g/l is most appropriate for most patients; further data are required for those with severe or critical vascular and circulatory diseases.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15682e243>Risk stratification</h2><p class="" id=d15682e246>There are many systems that have been used to stratify risks in upper GI bleeding. Probably the two most widely used and studied are the Rockall scores (both pre- and post-endoscopy) and the Glasgow–Blatchford score (GBS)<sup><a href="#ref-12">12</a></sup>. Although these have always been designed to assess somewhat different aspects, there continue to be studies comparing the clinical utility of these studies. It must be remembered that the Rockall scores assess mortality risk but were never designed directly as decision tools (accepting that the risk assessment of the patient clearly does inform clinical decision-making indirectly) but that the GBS was explicitly designed and validated to predict those cases not needing intervention (therapeutic endoscopy or blood transfusion). Thus, not surprisingly, the GBS consistently performs better in identifying lower-risk cases, suitable for direct discharge and outpatient management<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>. Further recent international validation of the GBS has confirmed that a score of 0 or 1 is associated with a very low risk of intervention and that hospital admission and emergency endoscopy are not required<sup><a href="#ref-15">15</a></sup>.</p><p class="" id=d15682e264>Further scores have been proposed. The AIMS65 score has been advocated as an even simpler score requiring scoring only on a 5-point score for each of the following factors: albumin of less than 30 g/l, international normalised ratio (&gt;1.5), Glasgow coma scale score of less than 14, systolic blood pressure of less than 90 mmHg, and age of more than 65. Although the AIMS65 can reliably predict mortality, it appears less accurate than the GBS in determining the need for interventions such as blood transfusion or admission to critical care<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>.</p><p class="" id=d15682e274>A further score, the Progetto Nazionale Emorragia Digestiva (PNED) score system, which relies on a rather complex multipart scoring using age, presence of cancer, renal failure, American Society of Anaesthesiologists grade, cirrhosis, rebleeding, and failure of endoscopic therapy, has been proposed. A large prospective study of over 3,000 patients confirmed that the GBS clearly performed best in identifying the lowest-risk patients and also in predicting interventions such as blood transfusion or endoscopic therapy. Although the PNED and AIMS65 scores were best at predicting mortality, none of the scores apart from the GBS appeared to be clinically useful in determining either the safety of outpatient management or the need for endoscopic therapy<sup><a href="#ref-15">15</a></sup>. A GBS of 7 or more was best at predicting the need for endoscopic treatment<sup><a href="#ref-15">15</a></sup>.</p><p class="" id=d15682e285>A further score based on seven factors—systolic blood pressure of less than 100 mmHg, syncope, haematemesis, haemoglobin of less than 100 g/l, blood urea of 22.4 mg/dl, estimated glomerular filtration rate of less than 60 mL/min per 1.73 m<sup>2</sup>, and the use of anti-platelet medications—was recently proposed<sup><a href="#ref-17">17</a></sup>. This score was superior to the pre-endoscopy Rockall and AIMS65 scores in predicting clinical intervention in a cohort of Japanese patients<sup><a href="#ref-17">17</a></sup> but has not been compared against the GBS or evaluated more widely.</p><p class="" id=d15682e300>Timing of emergency endoscopy in acute upper GI bleeding remains a controversial area, and although immediate endoscopy (as early as possible) seems theoretically attractive, this has not been supported by evidence. Studies have shown that very early endoscopy is not associated with better outcomes and in some cases is associated with worse outcomes (although this latter effect could have been an artefact of the design of the observational studies)<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. More recently, those patients with a GBS of 12 or more were shown (again in an observational study) to have lower mortality with a presentation to endoscopy time of more than 13 hours, whereas those with lower GBSs did not seem to benefit from such early endoscopy<sup><a href="#ref-20">20</a></sup>. This suggests that GBSs can be used both to triage patients not needing admission and to detect those who may benefit from relatively early endoscopy.</p><p class="" id=d15682e314>Further modifications of the GBS have also been reported, removing the most subjective of the criteria and relying merely on measurable haemodynamics and laboratory values, omitting the scoring for chronic disease/major comorbidities, melaena, and syncope. Interestingly, the abbreviated score seemed to perform as well as the full GBS and was again superior to the Rockall scores at predicting the need for clinical intervention<sup><a href="#ref-21">21</a></sup>. Whilst further validation studies are required, this may prove to be a useful modification in clinical practice.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15682e324>Endoscopy and endoscopic therapy</h2><p class="" id=d15682e327>Dual therapy, that is adrenaline/epinephrine infiltration plus either thermal coagulation with a bipolar probe or mechanical haemostasis with endoclips, remains the optimal endoscopic therapy advocated in major guidelines<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. However, the thermal or mechanical aspects are the most important, and although adrenaline is often used to clear the endoscopic field, it probably adds little to the haemostasis as secured by these other means<sup><a href="#ref-12">12</a></sup>. Although there are a variety of through-the-scope endoscopic clips available, there are no data showing clear superiority of any one type.</p><p class="" id=d15682e341>Within endoscopy, there are three important recent developments: Doppler probe-guided lesion assessment and treatment, large over-the-scope clips, and haemostatic powders. The exact place of all of these within the management pathway requires further assessment, but all seem to offer some advantages in certain circumstances.</p><p class="" id=d15682e344>Doppler probe assessment to detect significant arterial signals in the ulcer base had been reported many years previously<sup><a href="#ref-22">22</a></sup>. However, the lack of availability of the equipment and lack of convincing evidence of efficacy at the time rather precluded further adoption. More recently, there has been an increase in interest, stimulated by the availability of an easier-to-use Doppler unit and disposable, relatively low-cost endoscopic probes (Vascular Technologies Inc., Nashua, NH, USA). Two studies from the same group have shown initially how Doppler probe assessment is more accurate than classic endoscopic scoring at predicting rebleeding risks<sup><a href="#ref-23">23</a></sup> and secondly, in a randomised trial, that Doppler probe-guided management reduces rebleeding and further intervention compared with standard treatment<sup><a href="#ref-24">24</a></sup>. Doppler assessment showed that many oozing ulcers (Forrest 1b) are actually not associated with significant arterial flow into the ulcer (only 46.7% showed a positive Doppler signal) and that these ulcers are associated with a lower rebleeding rate than typically assumed. The rate of Doppler-positive arterial flow in oozing ulcers is actually significantly lower than the prevalence of positive Doppler signals for active arterial bleeding (100%), non-bleeding visible vessel (Forrest 2a, 90.7%), and those with adherent clot (Forrest 2b, 68.4%). Interestingly, 40.5% of ulcers with flat haem spots alone (Forrest 2c), which are classically associated with a low risk of rebleeding, had a positive arterial Doppler signal, whilst in clean-based ulcers (Forrest 3) only 8.3% had a positive Doppler signal. Repeating Doppler assessment post-standard endoscopic treatment showed a considerable reduction in arterial flow, and persistent arterial inflow was associated with an increased risk of rebleeding<sup><a href="#ref-23">23</a></sup>.</p><p class="" id=d15682e363>A subsequent randomised trial compared the use of the Doppler probe to inform both the indication for therapy and the success of that therapy against standard haemostatic treatment based purely on endoscopic visualisation<sup><a href="#ref-24">24</a></sup>. Endoscopic therapy was applied on the basis of the presence of a Doppler signal rather than endoscopic appearance, and after endoscopic therapy, the ulcer was re-interrogated and retreated if an arterial signal was still present. The Doppler probe allows clearer localisation of the feeding artery. Overall, Doppler use in this manner was associated with a significant reduction in rebleeding. Rates of rebleeding at 30 days were 8/72 (11.1%) in the Doppler-treated group and 20/76 (26.3%) in the standard care group. Residual arterial signal despite maximal endoscopic therapy (adrenaline, bipolar probe, through-the-scope clips) was strongly associated with rebleeding (8/9 cases, 88.9%) compared with 0/8 (0%) of those who had continued endoscopic retreatment until the Doppler signal was obliterated.</p><p class="" id=d15682e371>This technique looks very promising. The application of the Doppler probe allows more accurate definition of the rebleeding risk of ulcers (superior to standard endoscopic stigmata), facilitates tracing of the underlying artery for direction of haemostatic methods, and allows post-treatment interrogation to define the efficacy of endoscopic therapy. Further studies in other populations with less experienced and committed operators are required before widespread adoption, and further data on the efficacy of this advance are awaited with interest.</p><p class="" id=d15682e374>These data with the Doppler probe showing that oozing ulcers (Forrest 1b) are associated with significantly lower risks of rebleeding post-endoscopic therapy<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup> are in keeping with a retrospective analysis of data from one of the large studies of proton pump inhibitor (PPI) therapy after endoscopic therapy<sup><a href="#ref-25">25</a></sup>. In the placebo-treated group, rebleeding was much lower in those with oozing ulcers (4.9%) than in those with spurting (Forrest 1a, 22.5%), adherent clot (Forrest 2b, 17.6%), and visible vessel (Forrest 2a, 11.3%). It was previously thought that as oozing ulcers were seen to be ‘actively bleeding’ that these were high-risk lesions. These recent data confirm that Forrest 1b lesions tend to have smaller feeding arteries and hence rebleeding rates are lower than previously believed. Interestingly, this study also showed that intravenous esomeprazole did not reduce the already-low post-endoscopic rebleeding rate in the oozing ulcers (in comparison with the other high-risk stigmata), suggesting that parenteral acid suppression may be withheld from this group after successful haemostasis and standard oral therapy used<sup><a href="#ref-25">25</a></sup>. This reappraisal of rebleeding rates associated with classic endoscopic stigmata of recent haemorrhage has important implications for the interpretation of existing studies and the design of future studies as grouping all active bleeding groups (Forrest 1a and 1b) together now seems inappropriate given the clearly divergent rebleeding risks.</p><p class="" id=d15682e392>The main limitations of typical endoscopic clips are their relatively small size and the pressure that the jaw can apply to close tissue or provide mechanical haemostasis. The much larger and stronger over-the-scope endoscopic clip (OTSC, Ovesco Endoscopy, Tubingen, Germany) overcomes many of these drawbacks, being able to grasp larger and more fibrotic areas than standard clips and to apply more pressure onto feeding arteries. The obvious cost of this is having to preload the clip on the endoscope before intubation and much greater unit cost and sometimes difficulty passing the clip through the upper oesophageal sphincter. The OTSC clip is US Food and Drug Administration (FDA)-approved and available in many areas, being utilised to close fistulas and perforations in addition to acute PUB. Several case series have reported successful haemostasis with this device when other endoscopic methods have failed. Honegger <i>et al</i>.<sup><a href="#ref-26">26</a></sup> reported 85% success in treating PUB (28/35), although in a smaller case series, haemostatic success was reported in only 4/7 cases of refractory bleeding peptic ulcer<sup><a href="#ref-27">27</a></sup>. The OTSC clip has also been used successfully as primary treatment for PUB: Manno <i>et al</i>. reported 100% success in 21 cases<sup><a href="#ref-28">28</a></sup>. There are no randomised or indeed comparative studies available at present, but as a second-line endoscopic technique these clips seem to provide a further useful tool.</p><p class="" id=d15682e413>Haemostatic powders are in a similar position. These seem to be a promising technology but are not yet supported by comprehensive randomised trial data. There are now several powders commercially promoted in various geographical locations, the first being Hemospray (Cook Medical, Bloomington, IN, USA) but others are now available, although they are not yet FDA-approved for use in the USA. These are proprietary mineral preparations that, when sprayed onto a bleeding area through a cannula inserted through the channel of an endoscope, provoke rapid haemostasis. The powder acts as both a physical barrier upon contact with moisture and a powerful procoagulant by concentrating clotting factors at the site of application. Again, there are no randomised trials, but several case series showing successful haemostasis after failure of first-line endoscopic therapies show that this technique can also be usefully employed in the most difficult refractory bleeding ulcers. In a comprehensive literature review of reported cases, Hemospray was successful in 88% of 81 cases of bleeding peptic ulcers<sup><a href="#ref-29">29</a></sup>. Obviously, this method provides no destruction of the underlying artery (as clips or bipolar probes do), and the rate of rebleeding and the subsequent natural history of PUB bleeding in this manner are unknown. Haemostatic powders do not influence the underlying arterial inflow, and at present it is unclear whether rebleeding rates with highest-risk stigmata (spurting arteries or those with significant positive Doppler traces) are clinically problematical. The powder application invariably obscures the endoscopic view, and perhaps repeat second-look endoscopy will be required to perform more secure haemostasis. At present, this cannot be regarded as a routine first-line therapy but in some cases can be extremely useful when other methods have failed. The technique is relatively easy, although care must be taken to avoid premature exposure of the powder to liquid, which activates the powder. In the author’s experience, applying this in a duodenal cap with a rapidly bleeding artery is often quite difficult but can be applied for bleeding lesions when other methods are technically impossible or have failed and may provide rescue haemostasis in those cases. It is important to note that the requirement for blood or liquid for effective activation often precludes the use of haemostatic powders on non-bleeding but protuberant arteries (Forrest 2a lesions) that do merit some form of endoscopic therapy. Further data reporting the different haemostatic powders in relation to more standard haemostatic methods and in ulcers with different bleeding stigmata will help refine the place of the powders in management.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15682e424>Drug therapy</h2><p class="" id=d15682e427>Pre-endoscopy PPI infusion is recommended by some guidelines but not by all<sup><a href="#ref-12">12</a></sup>. Although this seems to downstage the endoscopic appearance of bleeding ulcers, the effect on hard clinical end-points such as rebleeding or hospital stay is debateable.</p><p class="" id=d15682e434>Post-endoscopy PPI treatment after endoscopic therapy to high-risk ulcers has repeatedly been shown to be better than placebo at reducing rebleeding and surgery<sup><a href="#ref-30">30</a></sup>. However, despite a multitude of studies, the optimal regimen is unclear. Many clinicians use the original ‘Hong Kong’ regimen (bolus followed by continuous infusion of omeprazole, pantoprazole, or esomeprazole) for 72 hours. Other dose regimens, including intermittent parenteral dosing and even high-dose oral PPI, have also been shown to be effective, and it is not clear what the optimal regimen is<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>. As previously discussed, the rebleeding rate after successful endoscopic haemostasis in oozing (Forrest 1b) ulcers is low and does not seem to be reduced by parenteral high-dose acid suppression and hence treatment may be rationalised in those patients to standard oral PPI therapy<sup><a href="#ref-25">25</a></sup>.</p><p class="" id=d15682e452>After endoscopic therapy and 72 hours intravenous PPI, high-dose oral acid suppression seems to be beneficial for highest-risk patients. Cheng <i>et al</i>.<sup><a href="#ref-33">33</a></sup> reported that 11 days of double-dose oral esomeprazole (40 mg twice daily) in this context was superior to once-daily esomeprazole 40 mg (with 40 mg once daily subsequently for both groups) in preventing rebleeding (10.8% versus 28.7% in the 4–28 days post-index bleed) in patients with a full Rockall score of 6 or more. There was no significant difference in mortality, hospital stay, or blood transfused. Thus, there is a rationale for treating the higher-risk patients (Rockall score of 6 or more) with higher-dose PPI for the period after initial stabilisation.</p><p class="" id=d15682e462>There is a sound rationale for using prokinetics before endoscopy in upper GI bleeding to clear the stomach and improve both the endoscopic views and probably safety. Individual trials have shown inconsistent results, but recent meta-analyses showed that intravenous erythromycin before endoscopy was associated with meaningful clinical benefit in terms of improved mucosal visualisation, reduction in repeat endoscopy, and blood transfused as well as length of stay but that metoclopramide was less effective<sup><a href="#ref-34">34</a>–<a href="#ref-36">36</a></sup>. Erythromycin is probably underused and seems to be a simple intervention that would improve outcomes.</p><p class="" id=d15682e473>The management of concurrent anticoagulation is an increasing problem for those involved in the care of acute PUB. The use of prothrombin complex concentrate to reverse the anticoagulation effects of vitamin K antagonists (VKAs) such as warfarin is well established<sup><a href="#ref-12">12</a></sup>. The direct-acting oral anticoagulants (DOACs), the thrombin antagonist dabigatran, and the factor X inhibitors apixaban, rivaroxaban, and edoxaban present more of a problem. Although the anticoagulation effect declines relatively rapidly because of renal clearance, life-threatening bleeding will require reversal in some patients. The first specific reversal agent for dabigatran has just been licenced and, though expensive, should be available to treat significant dabigatran-associated PUB. Idarucizumab is a monoclonal antibody against dabigatran and will not reverse the other DOACs<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. There are relatively few data on treatment of upper GI bleeding associated with these agents, although widespread use of tranexamic acid is not routinely indicated in PUB<sup><a href="#ref-39">39</a></sup> (although the results of the large worldwide HALT-IT trial are awaited with interest<sup><a href="#ref-40">40</a></sup>); in this particular situation, the use of tranexamic acid seems reasonable<sup><a href="#ref-41">41</a></sup>. Prothrombin complex concentrate seems to reverse the anticoagulation effect of factor X inhibitors in healthy volunteers and should probably be considered in severe life-threatening bleeding, although there are really no data specifically showing an effect in PUB<sup><a href="#ref-42">42</a></sup>. A specific antidote to factor Xa inhibition has been shown to rapidly reverse the anticoagulant effect and hopefully will be available for clinical use soon<sup><a href="#ref-43">43</a></sup>.</p><p class="" id=d15682e508>Acute upper GI bleeding is a significant drain on the iron stores of the body, and many patients are anaemic after initial management. A randomised trial compared subsequent management strategies in this group in non-variceal upper GI bleeding (mostly peptic ulcer-related). Iron therapy—either a one-off dose of ferric carboxymaltose or oral ferrous sulphate 200 mg daily—was more effective than placebo at restoring haemoglobin levels to normal. After 12 weeks, 70% of placebo-treated and 17% of iron-treated patients were still anaemic<sup><a href="#ref-44">44</a></sup>. There was no difference in the rates of improvement in anaemia between parenteral and enteral iron groups, although higher ferritin levels were seen in the parenteral group<sup><a href="#ref-44">44</a></sup>. There was no significant toxicity, and it seems logical that supplemental iron therapy should be used in those patients with anaemia at the cessation of the peptic ulcer bleed.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15682e522>Management of refractory bleeding</h2><p class="" id=d15682e525>Despite advances in endoscopic and pharmacological therapies, a significant minority of patients experience significant rebleeding. Surgery has traditionally been regarded as the appropriate approach. Increasingly, interventional radiology is regarded as the initial therapeutic approach before surgery. There are no randomised trials to guide therapy, nor are there likely to be. Though not supported by trial data, the author’s own practice is to place endoclips to mark the site of bleeding in those deemed at highest risk of needing embolization (most obviously in those with failed endoscopic haemostasis but also in those with technically difficult but successful haemostasis) to facilitate subsequent radiological localisation.</p><p class="" id=d15682e528>A number of case series have reported high technical success and acceptable complication rates with radiological embolization for acute PUB<sup><a href="#ref-45">45</a>–<a href="#ref-47">47</a></sup>, and it is believed that overall the safety of interventional radiological embolization is significantly better than surgery and hence most guidelines now advocate radiological embolization as the rescue therapy of choice. However, not all studies agree: single-centre observational studies and a meta-analysis have suggested that rates of rebleeding are higher following embolization and mortality rates equivalent<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup>. All such studies are somewhat difficult to interpret because of case mix: patients undergoing embolization tended to be older and have more comorbidities.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15682e548>Follow-up and prevention</h2><p class="" id=d15682e551>An understanding of the major causes of PUB naturally leads to developing strategies for both primary and secondary prevention. The major ameliorable causes of PUB are <i>Helicobacter pylori</i> and drugs, although it is important to note the apparent rise in idiopathic—non-<i>H. pylori</i>, non-aspirin/non-steroidal anti-inflammatory drug (NSAID)—ulcers.</p><p class="" id=d15682e560>Strategies to deal with <i>H. pylori</i> need to encompass both the declining efficacy of eradication therapies and the poor sensitivity of <i>H. pylori</i> testing in the context of PUB<sup><a href="#ref-50">50</a></sup>. Empirical eradication at the presentation with bleeding has been advocated in areas with a high prevalence of <i>H. pylori</i>, whilst an alternative approach of careful follow-up testing and focused treatment may be more applicable in areas with a low prevalence of <i>H. pylori</i>-induced ulcers<sup><a href="#ref-51">51</a></sup>. In any case, <i>H. pylori</i> eradication regimes must be effective in the population being treated and 14-day courses of four agents (either bismuth-containing or not) are now standard in Europe and the USA, although 7-day clarithromycin-containing regimens are still used in the UK in areas with a known low prevalence of clarithromycin-resistant <i>H. pylori</i> (for a full review of <i>H. pylori</i> eradication strategies, see the Maastricht V guidelines<sup><a href="#ref-52">52</a></sup>). It is essential that all those treating <i>H. pylori</i> are alert to the efficacy of their current treatment regimens and follow up patients assiduously.</p><p class="" id=d15682e600>For many years, it has been established that the sensitivity of all endoscopy-based <i>H. pylori</i> tests is lower in acute PUB<sup><a href="#ref-50">50</a></sup>. The reasons for this are unclear and are not as simple as being affected by blood in the lumen. The yield of biopsy-based tests can be significantly improved by taking additional biopsies from the gastric body<sup><a href="#ref-50">50</a></sup>, but owing to a residual false-negative rate, careful follow-up testing may still be more appropriate in those initially negative<sup><a href="#ref-51">51</a></sup>. In the acute bleeding setting, <sup>13</sup>C urea breath testing on return from endoscopy seems to be the most accurate test for <i>H. pylori</i> but many units find this logistically difficult to organise<sup><a href="#ref-50">50</a></sup>. In contrast, the faecal antigen test has a high false-positive rate in acute PUB, possibly due to cross-reaction with blood components in the GI lumen, and cannot be recommended for <i>H. pylori</i> testing in the acute setting<sup><a href="#ref-50">50</a></sup>. The diagnostic yield for <i>H. pylori</i> in the context of PUB can be significantly enhanced by performing diagnostic testing at least 4 weeks after the index bleed<sup><a href="#ref-53">53</a></sup>.</p><p class="" id=d15682e643>Although aspirin and other anti-platelet agents are clearly associated with an increased risk of PUB, in many cases these agents are indicated because of the underlying vascular disease, and it is now accepted that where indicated aspirin should be continued (or interrupted for a minimal interval of fewer than 3 days) in acute PUB<sup><a href="#ref-51">51</a></sup>. A small risk in early rebleeding is more than offset by a significantly reduced risk of vascular events and death. This approach is supported by data from both a relatively small clinical trial and observational follow-up data<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>.</p><p class="" id=d15682e658>The most appropriate treatment after an aspirin-induced bleed is aspirin plus a PPI<sup><a href="#ref-56">56</a></sup>; this is superior to the P<sub>2</sub>Y<sub>12</sub> antagonist clopidogrel alone as secondary treatment. There are fewer data on the newer P<sub>2</sub>Y<sub>12</sub> antagonists ticagrelor and prasugrel, but these are more potent anti-platelet agents, and not surprisingly the risk of GI bleeding seems to be higher than aspirin or clopidogrel<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. Patients with drug-eluting coronary artery stents do need to continue dual anti-platelet therapy for a year; PPI co-treatment reduces bleeding in those taking aspirin plus clopidogrel<sup><a href="#ref-59">59</a></sup>. The relative benefits and risks of aspirin plus PPI versus clopidogrel plus PPI after an aspirin-induced PUB are unclear. Observational data suggest that aspirin is safer, more effective, and preferable<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>. An interesting effect of the increased use of gastro-protection with anti-platelet agents is that as the incidence of upper GI bleeding has decreased, the incidence of lower GI bleeding has remained stable, such that in patients taking dual anti-platelet agents with PPI cover, the risk of lower GI bleeding is now approximately three times higher than that of upper GI bleeding<sup><a href="#ref-62">62</a></sup>.</p><p class="" id=d15682e700>In general, PPI co-treatment has been advocated with aspirin for primary and secondary prevention<sup><a href="#ref-51">51</a></sup>, although a recent study looking at secondary prevention in a Chinese population showed that famotidine was equivalent to rabeprazole<sup><a href="#ref-63">63</a></sup>. Previous data suggested that PPI treatment was better<sup><a href="#ref-64">64</a></sup>, and until more data in wider populations are available, PPI treatment remains the treatment of choice.</p><p class="" id=d15682e715>Similar to the case with anti-platelet agents, it is now becoming apparent that where indicated early resumption of anticoagulation for atrial fibrillation after a PUB is beneficial; again, a risk of rebleeding is more than offset by reductions in stroke and death. The exact optimal time for reintroduction of anticoagulation after a PUB is unclear; leaving reintroduction for 3 months imposes an excessive risk of thrombotic events<sup><a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>, whilst very early reintroduction does increase the rebleeding risk, and the compromise of reintroduction after 7–15 days seems to provide the optimal reduction in thromboembolic events compared with rebleeding<sup><a href="#ref-67">67</a>,<a href="#ref-68">68</a></sup>. More studies specifically examining this effect are required.</p><p class="" id=d15682e732>Previous studies have confirmed that selective COX-2 inhibitors are safer than traditional non-selective NSAIDs in terms of GI complications<sup><a href="#ref-51">51</a></sup>. The combination of celecoxib plus a PPI is associated with the lowest risk of rebleeding after an NSAID-induced PUB, when reintroduction of anti-inflammatory therapy is required<sup><a href="#ref-51">51</a></sup>. However, concerns about the cardiovascular safety of COX-2 inhibitors led to many clinicians being reluctant to prescribe these. More recent data suggest that the increased cardiovascular risk is common to all cyclo-oxygenase inhibitors, and a large randomised study powered to look at cardiovascular rather than GI outcomes showed no inferiority of celecoxib compared with either naproxen or ibuprofen: overall, cardiovascular adverse outcome rates were comparable but celecoxib was associated with a lower incidence of GI side effects<sup><a href="#ref-69">69</a></sup>. This suggests that when really necessary celecoxib (in a dose up to 200 mg daily) plus a full-dose PPI should not be withheld from patients requiring treatment after an NSAID-induced bleed.</p><p class="" id=d15682e747>PPI co-treatment would be usual after a PUB, and primary prevention of PUB in higher-risk patients taking anticoagulants is usually advocated by some but not all guidelines<sup><a href="#ref-51">51</a>,<a href="#ref-70">70</a>–<a href="#ref-73">73</a></sup>. Surprisingly, there are little data to specifically support this practice; one recent study showed that omeprazole co-treatment reduced rebleeding in warfarin-treated patients, although this effect was significant only in those also taking anti-platelet drugs or NSAIDs<sup><a href="#ref-74">74</a></sup>. A further observational study showed that concurrent use of PPIs or H2-receptor antagonists were both associated with a reduced risk of acute upper GI bleeding and this effect was most marked in those with a history of peptic ulcer disease<sup><a href="#ref-75">75</a></sup>. Therefore, despite the relative lack of evidence, co-prescription of gastroprotection with anticoagulant therapy would seem to be indicated in secondary prevention; for primary prevention, a case- and risk-based approach seems sensible pending further data. Those with highest risk of bleeding are most likely to gain from the use of acid suppression.</p><p class="" id=d15682e768>The rate of GI bleeding with DOACs compared with VKAs remains controversial. Whilst overall bleeding rates at all sites with DOACs do seem to be lower, this is mainly driven by a reduction in cerebral bleeding and the rate of GI bleeding may actually be increased but certainly does not seem convincingly lower. Several studies have shown either a higher rate of GI bleeding with DOACs or equivalent rates to VKAs<sup><a href="#ref-76">76</a>–<a href="#ref-79">79</a></sup>. The increased GI bleeding risk of DOACs seems especially marked in the most elderly (older than 76 years).</p><p class="" id=d15682e779>This effect on GI bleeding may be expected, as most of the DOACs are taken as active drugs (in contrast to VKAs) and relatively higher levels and local anticoagulant effects may be seen at the level of the GI mucosa. The choice of which anticoagulant (if any) to reintroduce after a PUB currently needs to be made on an individual basis, taking into account underlying risks and comorbidity, availability of antidotes, and patient preferences. It is clear that scoring systems for thrombotic risks in atrial fibrillation (CHADS<sub>2</sub>-Vasc) and bleeding risk (HAS-BLED) can give important guidance on the relative risks of these important outcomes<sup><a href="#ref-80">80</a></sup>; however, there are no data specifically related to how using these scores prospectively to inform management decisions influences outcomes.</p><p class="" id=d15682e789>Studies from disparate geographical regions have shown an important increase in apparently idiopathic peptic ulcers as the cause of upper GI bleeding. Although this was initially reported in the Far East, studies from the UK and Europe have provided support, and these ulcers can contribute up to 40% of ulcers in some series and an even higher proportion of bleeding peptic ulcers occurring in hospital inpatients<sup><a href="#ref-81">81</a>–<a href="#ref-84">84</a></sup>. Though labelled idiopathic, they are typically seen in a more elderly population with significant comorbidity and may represent a marker of systemic vascular pathology. The importance of recognising this group lies not only in allowing secondary preventative management of PUB by cause (<i>H. pylori</i>, drug, idiopathic) but also in appreciating that this group is associated with not only a significantly higher risk of rebleeding compared with other causes (up to 42% at 7 years) but also much higher all-cause mortality (presumably due to the associated comorbidity; 87% mortality at 7 years<sup><a href="#ref-85">85</a></sup>). Although continued acid suppression with a PPI is the logical intervention for this idiopathic ulcer group, one important study (albeit observational and not randomised) showed that acid suppression did not alter rebleeding or mortality in this group<sup><a href="#ref-86">86</a></sup>. Other approaches, perhaps with alternative mucosal protectant agents such as misoprostol, would seem to be warranted.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15682e813>Conclusions</h2><p class="" id=d15682e816>Acute PUB remains an important clinical problem, but the management continues to be refined. Important recent developments that can be incorporated into practice include the confirmation of the usefulness of the GBS in determining the lowest-risk patients, who may be safely managed as outpatients. The GBS is most useful for predicting the need for intervention, but another score—either the Rockall or the AIM65 score—should also be assessed as a predictor of mortality to aid assessment of outcomes.</p><p class="" id=d15682e819>A restrictive transfusion threshold with a trigger of 70 g/l and a target of 70–90 g/l is appropriate for most patients, although transfusion triggers need to be interpreted within the context of resuscitation of the individual patient. Pre-endoscopy erythromycin is probably underused, and recent evidence supports wider use to improve endoscopic views. The addition of high-dose oral esomeprazole after initial proton pump therapy in high-risk cases (Rockall scores of 6 and above) seems to have an additional benefit in reducing rebleeding. For endoscopic treatment, the haemostatic powders and over-the-scope clips are useful tools when standard modalities are ineffective or impractical. The new Doppler equipment and disposable endoscopic Doppler probe appear to be extremely promising in more accurately predicting ulcer rebleeding and the success of endoscopic therapy and are likely to be widely used if further studies are confirmatory.</p><p class="" id=d15682e822>Strategies to manage the bleeding episode and prevent rebleeding need to include the management of comorbidities and risks and at present must include the management of bleeding associated with all anti-thrombotic agents, but particularly the DOACs. Specific antidotes are being developed and are just entering the clinical arena. Recent data suggest that the cardiovascular risk of celecoxib is not excessive compared with standard NSAIDs, and when used appropriately, celecoxib should once again be a useful tool in the primary and secondary prevention of PUB. Non-<i>H. pylori</i>, non-NSAID ulcers are becoming an increasing problem with a poor prognosis, and further studies are urgently required to define the safest and most effective management.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d15682e1 class=n-a></a><h2 class=main-title id=d15976>Competing interests</h2><p class=metadata-entry><a name=d15682e75 class=n-a></a><p id=d15682e77> The author declares that he has no competing interests.</p></p></div><div class=back-section><a name=d15682e1 class=n-a></a><h2 class=main-title id=d15978>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d15682e832 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d16255>References</h2><div class="section ref-list"><a name=d15682e832 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d15682e839 class=n-a></a>Crooks CJ, West J, Card TR: Upper gastrointestinal haemorrhage and deprivation: a nationwide cohort study of health inequality in hospital admissions. <i>Gut.</i> 2012; <b>61</b>(4): 514–20. <a target=xrefwindow id=d15682e847 href="http://www.ncbi.nlm.nih.gov/pubmed/21757448">PubMed Abstract </a> | <a target=xrefwindow id=d15682e850 href="http://dx.doi.org/10.1136/gutjnl-2011-300186">Publisher Full Text </a> | <a target=xrefwindow id=d15682e853 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3292712">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d15682e862 class=n-a></a>Hearnshaw SA, Logan RF, Lowe D, <i> et al.</i>: Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. <i>Gut.</i> 2011; <b>60</b>(10): 1327–35. <a target=xrefwindow id=d15682e873 href="http://www.ncbi.nlm.nih.gov/pubmed/21490373">PubMed Abstract </a> | <a target=xrefwindow id=d15682e876 href="http://dx.doi.org/10.1136/gut.2010.228437">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d15682e885 class=n-a></a>Time to get control. London. NCEPOD. 2015. <a target=xrefwindow id=d15682e887 href="http://www.ncepod.org.uk/2015report1/downloads/TimeToGetControlFullReport.pdf">Reference Source</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d15682e896 class=n-a></a>Barkun AN, Bardou M, Kuipers EJ, <i> et al.</i>: International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. <i>Ann Intern Med.</i> 2010; <b>152</b>(2): 101–13. <a target=xrefwindow id=d15682e907 href="http://www.ncbi.nlm.nih.gov/pubmed/20083829">PubMed Abstract </a> | <a target=xrefwindow id=d15682e910 href="http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00009">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725818870"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e919 class=n-a></a>Gralnek IM, Dumonceau JM, Kuipers EJ, <i> et al.</i>: Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. <i>Endoscopy.</i> 2015; <b>47</b>(10): a1–46. <a target=xrefwindow id=d15682e930 href="http://www.ncbi.nlm.nih.gov/pubmed/26417980">PubMed Abstract </a> | <a target=xrefwindow id=d15682e933 href="http://dx.doi.org/10.1055/s-0034-1393172">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725818870">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717969084"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e947 class=n-a></a>Villanueva C, Colomo A, Bosch A, <i> et al.</i>: Transfusion strategies for acute upper gastrointestinal bleeding. <i>N Engl J Med.</i> 2013; <b>368</b>(1): 11–21. <a target=xrefwindow id=d15682e958 href="http://www.ncbi.nlm.nih.gov/pubmed/23281973">PubMed Abstract </a> | <a target=xrefwindow id=d15682e961 href="http://dx.doi.org/10.1056/NEJMoa1211801">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717969084">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d15682e974 class=n-a></a>Holst LB, Petersen MW, Haase N, <i> et al.</i>: Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. <i>BMJ.</i> 2015; <b>350</b>: h1354. <a target=xrefwindow id=d15682e985 href="http://www.ncbi.nlm.nih.gov/pubmed/25805204">PubMed Abstract </a> | <a target=xrefwindow id=d15682e988 href="http://dx.doi.org/10.1136/bmj.h1354">Publisher Full Text </a> | <a target=xrefwindow id=d15682e992 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4372223">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726130788"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1001 class=n-a></a>Holst LB: Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit. <i>Dan Med J.</i> 2016; <b>63</b>(2): pii: B5209. <a target=xrefwindow id=d15682e1009 href="http://www.ncbi.nlm.nih.gov/pubmed/26836806">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726130788">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d15682e1022 class=n-a></a>Jensen DM, Markovic D, Jensen ME, <i> et al.</i>: 784 Red Cell Transfusions Do Not Increase 30 Day Mortality Rates for Unselected Patients With Severe UGI Hemorrhage. <i>Gastroenterology.</i> 2015; <b>148</b>(4 supplement 1): S–154, [Abstract]. <a target=xrefwindow id=d15682e1033 href="http://dx.doi.org/10.1016/S0016-5085(15)30519-9">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d15682e1042 class=n-a></a>Wang J, Bao YX, Bai M, <i> et al.</i>: Restrictive <i>vs</i> liberal transfusion for upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. <i>World J Gastroenterol.</i> 2013; <b>19</b>(40): 6919–27. <a target=xrefwindow id=d15682e1056 href="http://www.ncbi.nlm.nih.gov/pubmed/24187470">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1060 href="http://dx.doi.org/10.3748/wjg.v19.i40.6919">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1063 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3812494">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727498736"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1072 class=n-a></a>Odutayo A, Desborough MJ, Trivella M, <i> et al.</i>: Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. <i>Lancet Gastroenterol Hepatol.</i> 2017; <b>2</b>(5): 354–60. <a target=xrefwindow id=d15682e1083 href="http://www.ncbi.nlm.nih.gov/pubmed/28397699">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1086 href="http://dx.doi.org/10.1016/S2468-1253(17)30054-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727498736">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d15682e1100 class=n-a></a>Beales IL: Recent advances in peptic ulcer bleeding. <i>F1000 Med Rep.</i> 2009; <b>1</b>: pii: 44. <a target=xrefwindow id=d15682e1108 href="http://www.ncbi.nlm.nih.gov/pubmed/20948737">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1111 href="http://dx.doi.org/10.3410/M1-44">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1114 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2924713">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729967276"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1123 class=n-a></a>Mokhtare M, Bozorgi V, Agah S, <i> et al.</i>: Comparison of Glasgow-Blatchford score and full Rockall score systems to predict clinical outcomes in patients with upper gastrointestinal bleeding. <i>Clin Exp Gastroenterol.</i> 2016; <b>9</b>: 337–43. <a target=xrefwindow id=d15682e1134 href="http://www.ncbi.nlm.nih.gov/pubmed/27826205">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1137 href="http://dx.doi.org/10.2147/CEG.S114860">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1141 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5096755">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729967276">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d15682e1154 class=n-a></a>Bryant RV, Kuo P, Williamson K, <i> et al.</i>: Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding. <i>Gastrointest Endosc.</i> 2013; <b>78</b>(4): 576–83. <a target=xrefwindow id=d15682e1165 href="http://www.ncbi.nlm.nih.gov/pubmed/23790755">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1168 href="http://dx.doi.org/10.1016/j.gie.2013.05.003">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727169850"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1177 class=n-a></a>Stanley AJ, Laine L, Dalton HR, <i> et al.</i>: Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. <i>BMJ.</i> 2017; <b>356</b>: i6432. <a target=xrefwindow id=d15682e1188 href="http://www.ncbi.nlm.nih.gov/pubmed/28053181">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1191 href="http://dx.doi.org/10.1136/bmj.i6432">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1195 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5217768">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727169850">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728805879"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1208 class=n-a></a>Palmer AJ, Moroni F, Mcleish S, <i> et al.</i>: Risk assessment in acute non-variceal upper GI bleeding: The AIMS65 score in comparison with the Glasgow-Blatchford score in a Scottish population. <i>Frontline Gastroenterol.</i> 2016; <b>7</b>(2): 90–6. <a target=xrefwindow id=d15682e1219 href="http://www.ncbi.nlm.nih.gov/pubmed/28839841">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1222 href="http://dx.doi.org/10.1136/flgastro-2015-100594">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1226 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5369468">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728805879">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726279475"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1239 class=n-a></a>Iino C, Mikami T, Igarashi T, <i> et al.</i>: Evaluation of scoring models for identifying the need for therapeutic intervention of upper gastrointestinal bleeding: A new prediction score model for Japanese patients. <i>Dig Endosc.</i> 2016; <b>28</b>(7): 714–21. <a target=xrefwindow id=d15682e1250 href="http://www.ncbi.nlm.nih.gov/pubmed/27061908">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1253 href="http://dx.doi.org/10.1111/den.12666">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726279475">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d15682e1267 class=n-a></a>Schacher GM, Lesbros-Pantoflickova D, Ortner MA, <i> et al.</i>: Is early endoscopy in the emergency room beneficial in patients with bleeding peptic ulcer? A "fortuitously controlled" study. <i>Endoscopy.</i> 2005; <b>37</b>(4): 324–8. <a target=xrefwindow id=d15682e1278 href="http://www.ncbi.nlm.nih.gov/pubmed/15824941">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1281 href="http://dx.doi.org/10.1055/s-2004-826237">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d15682e1290 class=n-a></a>Tai CM, Huang SP, Wang HP, <i> et al.</i>: High-risk ED patients with nonvariceal upper gastrointestinal hemorrhage undergoing emergency or urgent endoscopy: a retrospective analysis. <i>Am J Emerg Med.</i> 2007; <b>25</b>(3): 273–8. <a target=xrefwindow id=d15682e1301 href="http://www.ncbi.nlm.nih.gov/pubmed/17349900">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1304 href="http://dx.doi.org/10.1016/j.ajem.2006.07.014">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d15682e1313 class=n-a></a>Lim LG, Ho KY, Chan YH, <i> et al.</i>: Urgent endoscopy is associated with lower mortality in high-risk but not low-risk nonvariceal upper gastrointestinal bleeding. <i>Endoscopy.</i> 2011; <b>43</b>(4): 300–6. <a target=xrefwindow id=d15682e1324 href="http://www.ncbi.nlm.nih.gov/pubmed/21360421">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1327 href="http://dx.doi.org/10.1055/s-0030-1256110">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d15682e1336 class=n-a></a>Cheng DW, Lu YW, Teller T, <i> et al.</i>: A modified Glasgow Blatchford Score improves risk stratification in upper gastrointestinal bleed: a prospective comparison of scoring systems. <i>Aliment Pharmacol Ther.</i> 2012; <b>36</b>(8): 782–9. <a target=xrefwindow id=d15682e1347 href="http://www.ncbi.nlm.nih.gov/pubmed/22928529">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1350 href="http://dx.doi.org/10.1111/apt.12029">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d15682e1359 class=n-a></a>Fullarton GM, Murray WR: Prediction of rebleeding in peptic ulcers by visual stigmata and endoscopic Doppler ultrasound criteria. <i>Endoscopy.</i> 1990; <b>22</b>(2): 68–71. <a target=xrefwindow id=d15682e1367 href="http://www.ncbi.nlm.nih.gov/pubmed/2185930">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1370 href="http://dx.doi.org/10.1055/s-2007-1012795">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725755929"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1379 class=n-a></a>Jensen DM, Ohning GV, Kovacs TO, <i> et al.</i>: Doppler endoscopic probe as a guide to risk stratification and definitive hemostasis of peptic ulcer bleeding. <i>Gastrointest Endosc.</i> 2016; <b>83</b>(1): 129–36. <a target=xrefwindow id=d15682e1390 href="http://www.ncbi.nlm.nih.gov/pubmed/26318834">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1393 href="http://dx.doi.org/10.1016/j.gie.2015.07.012">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1397 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4691549">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725755929">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727289169"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1411 class=n-a></a>Jensen DM, Kovacs TOG, Ohning GV, <i> et al.</i>: Doppler Endoscopic Probe Monitoring of Blood Flow Improves Risk Stratification and Outcomes of Patients With Severe Nonvariceal Upper Gastrointestinal Hemorrhage. <i>Gastroenterology.</i> 2017; <b>152</b>(6): 1310–1318.e1. <a target=xrefwindow id=d15682e1422 href="http://www.ncbi.nlm.nih.gov/pubmed/28167214">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1425 href="http://dx.doi.org/10.1053/j.gastro.2017.01.042">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727289169">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727215770"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1438 class=n-a></a>Jensen DM, Eklund S, Persson T, <i> et al.</i>: Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial. <i>Am J Gastroenterol.</i> 2017; <b>112</b>(3): 441–6. <a target=xrefwindow id=d15682e1449 href="http://www.ncbi.nlm.nih.gov/pubmed/28094314">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1452 href="http://dx.doi.org/10.1038/ajg.2016.582">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727215770">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731143853"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1465 class=n-a></a>Honegger C, Valli PV, Wiegand N, <i> et al.</i>: Establishment of Over-The-Scope-Clips (OTSC®) in daily endoscopic routine. <i>United European Gastroenterol J.</i> 2017; <b>5</b>(2): 247–54. <a target=xrefwindow id=d15682e1476 href="http://www.ncbi.nlm.nih.gov/pubmed/28344792">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1479 href="http://dx.doi.org/10.1177/2050640616657273">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1483 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5349362">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731143853">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d15682e1496 class=n-a></a>Chan SM, Chiu PW, Teoh AY, <i> et al.</i>: Use of the Over-The-Scope Clip for treatment of refractory upper gastrointestinal bleeding: a case series. <i>Endoscopy.</i> 2014; <b>46</b>(5): 428–31. <a target=xrefwindow id=d15682e1507 href="http://www.ncbi.nlm.nih.gov/pubmed/24505017">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1510 href="http://dx.doi.org/10.1055/s-0034-1364932">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725668622"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1519 class=n-a></a>Manno M, Mangiafico S, Caruso A, <i> et al.</i>: First-line endoscopic treatment with OTSC in patients with high-risk non-variceal upper gastrointestinal bleeding: preliminary experience in 40 cases. <i>Surg Endosc.</i> 2016; <b>30</b>(5): 2026–9. <a target=xrefwindow id=d15682e1530 href="http://www.ncbi.nlm.nih.gov/pubmed/26201415">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1533 href="http://dx.doi.org/10.1007/s00464-015-4436-y">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725668622">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728255382"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1546 class=n-a></a>Changela K, Papafragkakis H, Ofori E, <i> et al.</i>: Hemostatic powder spray: a new method for managing gastrointestinal bleeding. <i>Therap Adv Gastroenterol.</i> 2015; <b>8</b>(3): 125–35. <a target=xrefwindow id=d15682e1557 href="http://www.ncbi.nlm.nih.gov/pubmed/26082803">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1560 href="http://dx.doi.org/10.1177/1756283X15572587">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1564 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4454021">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728255382">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d15682e1578 class=n-a></a>Leontiadis GI, Sharma VK, Howden CW: Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials. <i>Mayo Clin Proc.</i> 2007; <b>82</b>(3): 286–96. <a target=xrefwindow id=d15682e1586 href="http://www.ncbi.nlm.nih.gov/pubmed/17352364">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1589 href="http://dx.doi.org/10.4065/82.3.286">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718059822"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1598 class=n-a></a>Tsoi KK, Hirai HW, Sung JJ: Meta-analysis: comparison of oral vs. intravenous proton pump inhibitors in patients with peptic ulcer bleeding. <i>Aliment Pharmacol Ther.</i> 2013; <b>38</b>(7): 721–8. <a target=xrefwindow id=d15682e1606 href="http://www.ncbi.nlm.nih.gov/pubmed/23915096">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1609 href="http://dx.doi.org/10.1111/apt.12441">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718059822">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718019264"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1622 class=n-a></a>Neumann I, Letelier LM, Rada G, <i> et al.</i>: Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding. <i>Cochrane Database Syst Rev.</i> 2013; (6): CD007999. <a target=xrefwindow id=d15682e1630 href="http://www.ncbi.nlm.nih.gov/pubmed/23760821">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1633 href="http://dx.doi.org/10.1002/14651858.CD007999.pub2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718019264">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d15682e1646 class=n-a></a>Cheng HC, Wu CT, Chang WL, <i> et al.</i>: Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study. <i>Gut.</i> 2014; <b>63</b>(12): 1864–72. <a target=xrefwindow id=d15682e1657 href="http://www.ncbi.nlm.nih.gov/pubmed/24658598">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1660 href="http://dx.doi.org/10.1136/gutjnl-2013-306531">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d15682e1669 class=n-a></a>Theivanayagam S, Lim RG, Cobell WJ, <i> et al.</i>: Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. <i>Saudi J Gastroenterol.</i> 2013; <b>19</b>(5): 205–10. <a target=xrefwindow id=d15682e1680 href="http://www.ncbi.nlm.nih.gov/pubmed/24045593">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1683 href="http://dx.doi.org/10.4103/1319-3767.118120">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1687 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3793471">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d15682e1696 class=n-a></a>Szary NM, Gupta R, Choudhary A, <i> et al.</i>: Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. <i>Scand J Gastroenterol.</i> 2011; <b>46</b>(7–8): 920–4. <a target=xrefwindow id=d15682e1707 href="http://www.ncbi.nlm.nih.gov/pubmed/21561232">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1710 href="http://dx.doi.org/10.3109/00365521.2011.568520">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d15682e1720 class=n-a></a>Daram SR, Garretson R: Erythromycin is preferable to metoclopramide as a prokinetic in acute upper GI bleeding. <i>Gastrointest Endosc.</i> 2011; <b>74</b>(1): 234; author reply 234–5. <a target=xrefwindow id=d15682e1728 href="http://www.ncbi.nlm.nih.gov/pubmed/21704823">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1731 href="http://dx.doi.org/10.1016/j.gie.2011.01.059">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725571445"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1740 class=n-a></a>Glund S, Stangier J, Schmohl M, <i> et al.</i>: Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial. <i>Lancet.</i> 2015; <b>386</b>(9994): 680–90. <a target=xrefwindow id=d15682e1751 href="http://www.ncbi.nlm.nih.gov/pubmed/26088268">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1754 href="http://dx.doi.org/10.1016/S0140-6736(15)60732-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725571445">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725579799"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1767 class=n-a></a>Pollack CV Jr, Reilly PA, Eikelboom J, <i> et al.</i>: Idarucizumab for Dabigatran Reversal. <i>N Engl J Med.</i> 2015; <b>373</b>(6): 511–20. <a target=xrefwindow id=d15682e1778 href="http://www.ncbi.nlm.nih.gov/pubmed/26095746">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1781 href="http://dx.doi.org/10.1056/NEJMoa1502000">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725579799">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d15682e1794 class=n-a></a>Bennett C, Klingenberg SL, Langholz E, <i> et al.</i>: Tranexamic acid for upper gastrointestinal bleeding. <i>Cochrane Database Syst Rev.</i> 2014; (11): CD006640. <a target=xrefwindow id=d15682e1802 href="http://www.ncbi.nlm.nih.gov/pubmed/25414987">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1805 href="http://dx.doi.org/10.1002/14651858.CD006640.pub3">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d15682e1814 class=n-a></a>Roberts I, Coats T, Edwards P, <i> et al.</i>: HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. <i>Trials.</i> 2014; <b>15</b>: 450. <a target=xrefwindow id=d15682e1825 href="http://www.ncbi.nlm.nih.gov/pubmed/25409738">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1828 href="http://dx.doi.org/10.1186/1745-6215-15-450">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1832 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4253634">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731147287"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1841 class=n-a></a>Veitch AM, Vanbiervliet G, Gershlick AH, <i> et al.</i>: Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. <i>Endoscopy.</i> 2016; <b>48</b>(4): c1. <a target=xrefwindow id=d15682e1852 href="http://www.ncbi.nlm.nih.gov/pubmed/28114689">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1855 href="http://dx.doi.org/10.1055/s-0042-122686">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731147287">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727347787"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1869 class=n-a></a>Schultz NH, Tran HTT, Bjørnsen S, <i> et al.</i>: The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor. <i>Thromb J.</i> 2017; <b>15</b>: 6. <a target=xrefwindow id=d15682e1880 href="http://www.ncbi.nlm.nih.gov/pubmed/28239301">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1883 href="http://dx.doi.org/10.1186/s12959-017-0129-1">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1887 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5319105">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727347787">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726696410"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e1900 class=n-a></a>Connolly SJ, Milling TJ Jr, Eikelboom JW, <i> et al.</i>: Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. <i>N Engl J Med.</i> 2016; <b>375</b>(12): 1131–41. <a target=xrefwindow id=d15682e1911 href="http://www.ncbi.nlm.nih.gov/pubmed/27573206">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1914 href="http://dx.doi.org/10.1056/NEJMoa1607887">Publisher Full Text </a> | <a target=xrefwindow id=d15682e1918 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5568772">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726696410">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d15682e1931 class=n-a></a>Bager P, Dahlerup JF: Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage--a placebo-controlled study. <i>Aliment Pharmacol Ther.</i> 2014; <b>39</b>(2): 176–87. <a target=xrefwindow id=d15682e1939 href="http://www.ncbi.nlm.nih.gov/pubmed/24251969">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1942 href="http://dx.doi.org/10.1111/apt.12556">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d15682e1951 class=n-a></a>Wong TC, Wong K, Chiu PW, <i> et al.</i>: A comparison of angiographic embolization with surgery after failed endoscopic hemostasis to bleeding peptic ulcers. <i>Gastrointest Endosc.</i> 2011; <b>73</b>(5): 900–8. <a target=xrefwindow id=d15682e1962 href="http://www.ncbi.nlm.nih.gov/pubmed/21288512">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1965 href="http://dx.doi.org/10.1016/j.gie.2010.11.024">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d15682e1974 class=n-a></a>Katano T, Mizoshita T, Senoo K, <i> et al.</i>: The efficacy of transcatheter arterial embolization as the first-choice treatment after failure of endoscopic hemostasis and endoscopic treatment resistance factors. <i>Dig Endosc.</i> 2012; <b>24</b>(5): 364–9. <a target=xrefwindow id=d15682e1985 href="http://www.ncbi.nlm.nih.gov/pubmed/22925291">PubMed Abstract </a> | <a target=xrefwindow id=d15682e1988 href="http://dx.doi.org/10.1111/j.1443-1661.2012.01285.x">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d15682e1997 class=n-a></a>Lee HH, Park JM, Chun HJ, <i> et al.</i>: Transcatheter arterial embolization for endoscopically unmanageable non-variceal upper gastrointestinal bleeding. <i>Scand J Gastroenterol.</i> 2015; <b>50</b>(7): 809–15. <a target=xrefwindow id=d15682e2008 href="http://www.ncbi.nlm.nih.gov/pubmed/25732964">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2011 href="http://dx.doi.org/10.3109/00365521.2014.990503">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d15682e2021 class=n-a></a>Kyaw M, Tse Y, Ang D, <i> et al.</i>: Embolization versus surgery for peptic ulcer bleeding after failed endoscopic hemostasis: a meta-analysis. <i>Endosc Int Open.</i> 2014; <b>2</b>(1): E6–E14. <a target=xrefwindow id=d15682e2032 href="http://www.ncbi.nlm.nih.gov/pubmed/26134614">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2035 href="http://dx.doi.org/10.1055/s-0034-1365235">Publisher Full Text </a> | <a target=xrefwindow id=d15682e2039 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4423253">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728696981"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2048 class=n-a></a>Griffiths EA, McDonald CR, Bryant RV, <i> et al.</i>: Retrospective analysis of surgery and trans-arterial embolization for major non-variceal upper gastrointestinal bleeding. <i>ANZ J Surg.</i> 2016; <b>86</b>(5): 381–5. <a target=xrefwindow id=d15682e2059 href="http://www.ncbi.nlm.nih.gov/pubmed/24698113">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2062 href="http://dx.doi.org/10.1111/ans.12588">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728696981">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d15682e2075 class=n-a></a>Gisbert JP, Abraira V: Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. <i>Am J Gastroenterol.</i> 2006; <b>101</b>(4): 848–63. <a target=xrefwindow id=d15682e2083 href="http://www.ncbi.nlm.nih.gov/pubmed/16494583">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2086 href="http://dx.doi.org/10.1111/j.1572-0241.2006.00528.x">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d15682e2095 class=n-a></a>Brooks J, Warburton R, Beales IL: Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance. <i>Ther Adv Chronic Dis.</i> 2013; <b>4</b>(5): 206–22. <a target=xrefwindow id=d15682e2103 href="http://www.ncbi.nlm.nih.gov/pubmed/23997925">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2106 href="http://dx.doi.org/10.1177/2040622313492188">Publisher Full Text </a> | <a target=xrefwindow id=d15682e2109 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3752180">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726818364"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2118 class=n-a></a>Malfertheiner P, Megraud F, O'Morain CA, <i> et al.</i>: Management of <i>Helicobacter pylori</i> infection-the Maastricht V/Florence Consensus Report. <i>Gut.</i> 2017; <b>66</b>(1): 6–30. <a target=xrefwindow id=d15682e2132 href="http://www.ncbi.nlm.nih.gov/pubmed/27707777">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2136 href="http://dx.doi.org/10.1136/gutjnl-2016-312288">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726818364">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d15682e2149 class=n-a></a>Sánchez-Delgado J, Gené E, Suárez D, <i> et al.</i>: Has <i>H. pylori</i> prevalence in bleeding peptic ulcer been underestimated? A meta-regression. <i>Am J Gastroenterol.</i> 2011; <b>106</b>(3): 398–405. <a target=xrefwindow id=d15682e2163 href="http://www.ncbi.nlm.nih.gov/pubmed/21304499">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2167 href="http://dx.doi.org/10.1038/ajg.2011.2">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1256012"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2177 class=n-a></a>Sung JJ, Lau JY, Ching JY, <i> et al.</i>: Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. <i>Ann Intern Med.</i> 2010; <b>152</b>(1): 1–9. <a target=xrefwindow id=d15682e2188 href="http://www.ncbi.nlm.nih.gov/pubmed/19949136">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2191 href="http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00179">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1256012">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717989814"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2204 class=n-a></a>Derogar M, Sandblom G, Lundell L, <i> et al.</i>: Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. <i>Clin Gastroenterol Hepatol.</i> 2013; <b>11</b>(1): 38–42. <a target=xrefwindow id=d15682e2215 href="http://www.ncbi.nlm.nih.gov/pubmed/22975385">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2218 href="http://dx.doi.org/10.1016/j.cgh.2012.08.034">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717989814">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d15682e2231 class=n-a></a>Lai KC, Chu KM, Hui WM, <i> et al.</i>: Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. <i>Clin Gastroenterol Hepatol.</i> 2006; <b>4</b>(7): 860–5. <a target=xrefwindow id=d15682e2242 href="http://www.ncbi.nlm.nih.gov/pubmed/16797240">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2245 href="http://dx.doi.org/10.1016/j.cgh.2006.04.019">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717965979"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2254 class=n-a></a>Wallentin L, Becker RC, Budaj A, <i> et al.</i>: Ticagrelor versus clopidogrel in patients with acute coronary syndromes. <i>N Engl J Med.</i> 2009; <b>361</b>(11): 1045–57. <a target=xrefwindow id=d15682e2265 href="http://www.ncbi.nlm.nih.gov/pubmed/19717846">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2268 href="http://dx.doi.org/10.1056/NEJMoa0904327">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717965979">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726995982"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2281 class=n-a></a>Xin YG, Zhang HS, Li YZ, <i> et al.</i>: Efficacy and safety of ticagrelor versus clopidogrel with different dosage in high-risk patients with acute coronary syndrome. <i>Int J Cardiol.</i> 2017; <b>228</b>: 275–9. <a target=xrefwindow id=d15682e2292 href="http://www.ncbi.nlm.nih.gov/pubmed/27865197">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2295 href="http://dx.doi.org/10.1016/j.ijcard.2016.11.160">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726995982">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/7131956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2308 class=n-a></a>Bhatt DL, Cryer BL, Contant CF, <i> et al.</i>: Clopidogrel with or without omeprazole in coronary artery disease. <i>N Engl J Med.</i> 2010; <b>363</b>(20): 1909–17. <a target=xrefwindow id=d15682e2319 href="http://www.ncbi.nlm.nih.gov/pubmed/20925534">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2322 href="http://dx.doi.org/10.1056/NEJMoa1007964">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/7131956">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d15682e2336 class=n-a></a>Ng FH, Wong BC, Wong SY, <i> et al.</i>: Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk -- a single-blind, randomized controlled study. <i>Aliment Pharmacol Ther.</i> 2004; <b>19</b>(3): 359–65. <a target=xrefwindow id=d15682e2347 href="http://www.ncbi.nlm.nih.gov/pubmed/14984383">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2350 href="http://dx.doi.org/10.1111/j.1365-2036.2004.01857.x">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d15682e2359 class=n-a></a>Hsiao FY, Tsai YW, Huang WF, <i> et al.</i>: A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. <i>Clin Ther.</i> 2009; <b>31</b>(9): 2038–47. <a target=xrefwindow id=d15682e2370 href="http://www.ncbi.nlm.nih.gov/pubmed/19843493">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2373 href="http://dx.doi.org/10.1016/j.clinthera.2009.09.005">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d15682e2382 class=n-a></a>Casado Arroyo R, Polo-Tomas M, Roncalés MP, <i> et al.</i>: Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy. <i>Heart.</i> 2012; <b>98</b>(9): 718–23. <a target=xrefwindow id=d15682e2393 href="http://www.ncbi.nlm.nih.gov/pubmed/22523056">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2396 href="http://dx.doi.org/10.1136/heartjnl-2012-301632">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726756013"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2405 class=n-a></a>Chan FK, Kyaw M, Tanigawa T, <i> et al.</i>: Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin. <i>Gastroenterology.</i> 2017; <b>152</b>(1): 105–110.e1. <a target=xrefwindow id=d15682e2416 href="http://www.ncbi.nlm.nih.gov/pubmed/27641510">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2419 href="http://dx.doi.org/10.1053/j.gastro.2016.09.006">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726756013">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1797972"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2432 class=n-a></a>Ng FH, Wong SY, Lam KF, <i> et al.</i>: Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. <i>Gastroenterology.</i> 2010; <b>138</b>(1): 82–8. <a target=xrefwindow id=d15682e2443 href="http://www.ncbi.nlm.nih.gov/pubmed/19837071">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2446 href="http://dx.doi.org/10.1053/j.gastro.2009.09.063">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1797972">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725277111"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2459 class=n-a></a>Sengupta N, Feuerstein JD, Patwardhan VR, <i> et al.</i>: The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. <i>Am J Gastroenterol.</i> 2015; <b>110</b>(2): 328–35. <a target=xrefwindow id=d15682e2470 href="http://www.ncbi.nlm.nih.gov/pubmed/25512338">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2473 href="http://dx.doi.org/10.1038/ajg.2014.398">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725277111">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d15682e2487 class=n-a></a>Staerk L, Lip GY, Olesen JB, <i> et al.</i>: Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. <i>BMJ.</i> 2015; <b>351</b>: h5876. <a target=xrefwindow id=d15682e2498 href="http://www.ncbi.nlm.nih.gov/pubmed/26572685">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2501 href="http://dx.doi.org/10.1136/bmj.h5876">Publisher Full Text </a> | <a target=xrefwindow id=d15682e2505 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4646074">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d15682e2514 class=n-a></a>Beales IL: Decisions on restarting anticoagulation should be made earlier after rebleeding. <i>BMJ.</i> 2016; <b>532</b>: i248. <a target=xrefwindow id=d15682e2522 href="http://www.ncbi.nlm.nih.gov/pubmed/26791044">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2525 href="http://dx.doi.org/10.1136/bmj.i248">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727381105"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2534 class=n-a></a>Scott MJ, Veitch A, Thachil J: Reintroduction of anti-thrombotic therapy after a gastrointestinal haemorrhage: if and when? <i>Br J Haematol.</i> 2017; <b>177</b>(2): 185–97. <a target=xrefwindow id=d15682e2542 href="http://www.ncbi.nlm.nih.gov/pubmed/28272736">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2545 href="http://dx.doi.org/10.1111/bjh.14599">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727381105">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726966250"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2558 class=n-a></a>Nissen SE, Yeomans ND, Solomon DH, <i> et al.</i>: Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. <i>N Engl J Med.</i> 2016; <b>375</b>(26): 2519–29. <a target=xrefwindow id=d15682e2569 href="http://www.ncbi.nlm.nih.gov/pubmed/27959716">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2572 href="http://dx.doi.org/10.1056/NEJMoa1611593">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726966250">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d15682e2585 class=n-a></a>Ansell J, Hirsh J, Hylek E, <i> et al.</i>: Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). <i>Chest.</i> 2008; <b>133</b>(6 Suppl): 160S–198S. <a target=xrefwindow id=d15682e2596 href="http://www.ncbi.nlm.nih.gov/pubmed/18574265">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2599 href="http://dx.doi.org/10.1378/chest.08-0670">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d15682e2608 class=n-a></a>Schulman S, Beyth RJ, Kearon C, <i> et al.</i>: Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). <i>Chest.</i> 2008; <b>133</b>(6 Suppl): 257S–298S. <a target=xrefwindow id=d15682e2619 href="http://www.ncbi.nlm.nih.gov/pubmed/18574268">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2622 href="http://dx.doi.org/10.1378/chest.08-0674">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d15682e2632 class=n-a></a>Garcia DA, Witt DM, Hylek E, <i> et al.</i>: Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum. <i>Ann Pharmacother.</i> 2008; <b>42</b>(7): 979–88. <a target=xrefwindow id=d15682e2643 href="http://www.ncbi.nlm.nih.gov/pubmed/18559954">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2646 href="http://dx.doi.org/10.1345/aph.1L098">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d15682e2655 class=n-a></a>January CT, Wann LS, Alpert JS, <i> et al.</i>: 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. <i>J Am Coll Cardiol.</i> 2014; <b>64</b>(21): e1–76. <a target=xrefwindow id=d15682e2666 href="http://www.ncbi.nlm.nih.gov/pubmed/24685669">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2669 href="http://dx.doi.org/10.1016/j.jacc.2014.03.022">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726749153"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2678 class=n-a></a>Ray WA, Chung CP, Murray KT, <i> et al.</i>: Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding. <i>Gastroenterology.</i> 2016; <b>151</b>(6): 1105–1112.e10. <a target=xrefwindow id=d15682e2689 href="http://www.ncbi.nlm.nih.gov/pubmed/27639805">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2692 href="http://dx.doi.org/10.1053/j.gastro.2016.08.054">Publisher Full Text </a> | <a target=xrefwindow id=d15682e2696 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5124401">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726749153">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d15682e2709 class=n-a></a>Chan EW, Lau WC, Leung WK, <i> et al.</i>: Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study. <i>Gastroenterology.</i> 2015; <b>149</b>(3): 586–95.e3. <a target=xrefwindow id=d15682e2720 href="http://www.ncbi.nlm.nih.gov/pubmed/25960019">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2723 href="http://dx.doi.org/10.1053/j.gastro.2015.05.002">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725970752"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2732 class=n-a></a>Sherwood MW, Nessel CC, Hellkamp AS, <i> et al.</i>: Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. <i>J Am Coll Cardiol.</i> 2015; <b>66</b>(21): 2271–81. <a target=xrefwindow id=d15682e2743 href="http://www.ncbi.nlm.nih.gov/pubmed/26610874">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2746 href="http://dx.doi.org/10.1016/j.jacc.2015.09.024">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725970752">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718201417"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2759 class=n-a></a>Ruff CT, Giugliano RP, Braunwald E, <i> et al.</i>: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. <i>Lancet.</i> 2014; <b>383</b>(9921): 955–62. <a target=xrefwindow id=d15682e2770 href="http://www.ncbi.nlm.nih.gov/pubmed/24315724">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2773 href="http://dx.doi.org/10.1016/S0140-6736(13)62343-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718201417">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717995230"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2787 class=n-a></a>Holster IL, Valkhoff VE, Kuipers EJ, <i> et al.</i>: New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. <i>Gastroenterology.</i> 2013; <b>145</b>(1): 105–112.e15. <a target=xrefwindow id=d15682e2798 href="http://www.ncbi.nlm.nih.gov/pubmed/23470618">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2801 href="http://dx.doi.org/10.1053/j.gastro.2013.02.041">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717995230">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d15682e2814 class=n-a></a>Abraham NS, Singh S, Alexander GC, <i> et al.</i>: Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. <i>BMJ.</i> 2015; <b>350</b>: h1857. <a target=xrefwindow id=d15682e2825 href="http://www.ncbi.nlm.nih.gov/pubmed/25910928">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2828 href="http://dx.doi.org/10.1136/bmj.h1857">Publisher Full Text </a> | <a target=xrefwindow id=d15682e2832 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4413863">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718304415"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2841 class=n-a></a>Pisters R, Lane DA, Nieuwlaat R, <i> et al.</i>: A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. <i>Chest.</i> 2010; <b>138</b>(5): 1093–100. <a target=xrefwindow id=d15682e2852 href="http://www.ncbi.nlm.nih.gov/pubmed/20299623">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2855 href="http://dx.doi.org/10.1378/chest.10-0134">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718304415">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d15682e2868 class=n-a></a>Dore MP, Marras G, Rocchi C, <i> et al.</i>: Changing prevalence of <i>Helicobacter pylori</i> infection and peptic ulcer among dyspeptic Sardinian patients. <i>Intern Emerg Med.</i> 2015; <b>10</b>(7): 787–94. <a target=xrefwindow id=d15682e2882 href="http://www.ncbi.nlm.nih.gov/pubmed/25739590">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2886 href="http://dx.doi.org/10.1007/s11739-015-1218-4">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d15682e2895 class=n-a></a>Kanno T, Iijima K, Abe Y, <i> et al.</i>: A multicenter prospective study on the prevalence of <i>Helicobacter pylori</i>-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan. <i>J Gastroenterol Hepatol.</i> 2015; <b>30</b>(5): 842–8. <a target=xrefwindow id=d15682e2909 href="http://www.ncbi.nlm.nih.gov/pubmed/25532720">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2913 href="http://dx.doi.org/10.1111/jgh.12876">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d15682e2922 class=n-a></a>Charpignon C, Lesgourgues B, Pariente A, <i> et al.</i>: Peptic ulcer disease: one in five is related to neither <i>Helicobacter pylori</i> nor aspirin/NSAID intake. <i>Aliment Pharmacol Ther.</i> 2013; <b>38</b>(8): 946–54. <a target=xrefwindow id=d15682e2936 href="http://www.ncbi.nlm.nih.gov/pubmed/23981105">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2940 href="http://dx.doi.org/10.1111/apt.12465">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d15682e2950 class=n-a></a>Musumba C, Jorgensen A, Sutton L, <i> et al.</i>: The relative contribution of NSAIDs and <i>Helicobacter pylori</i> to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. <i>Aliment Pharmacol Ther.</i> 2012; <b>36</b>(1): 48–56. <a target=xrefwindow id=d15682e2964 href="http://www.ncbi.nlm.nih.gov/pubmed/22554233">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2968 href="http://dx.doi.org/10.1111/j.1365-2036.2012.05118.x">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1164883"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e2977 class=n-a></a>Wong GL, Wong VW, Chan Y, <i> et al.</i>: High incidence of mortality and recurrent bleeding in patients with <i>Helicobacter pylori</i>-negative idiopathic bleeding ulcers. <i>Gastroenterology.</i> 2009; <b>137</b>(2): 525–31. <a target=xrefwindow id=d15682e2991 href="http://www.ncbi.nlm.nih.gov/pubmed/19445937">PubMed Abstract </a> | <a target=xrefwindow id=d15682e2995 href="http://dx.doi.org/10.1053/j.gastro.2009.05.006">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1164883">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717973240"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15682e3008 class=n-a></a>Wong GL, Au KW, Lo AO, <i> et al.</i>: Gastroprotective therapy does not improve outcomes of patients with <i>Helicobacter pylori</i>-negative idiopathic bleeding ulcers. <i>Clin Gastroenterol Hepatol.</i> 2012; <b>10</b>(10): 1124–9. <a target=xrefwindow id=d15682e3022 href="http://www.ncbi.nlm.nih.gov/pubmed/22732269">PubMed Abstract </a> | <a target=xrefwindow id=d15682e3026 href="http://dx.doi.org/10.1016/j.cgh.2012.06.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717973240">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1763.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1763.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, UK<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1763/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 27 Sep 2017, 6:1763 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11286.1">https://doi.org/10.12688/f1000research.11286.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Beales I. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12175 data-id=11286 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11286.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1763/v1/pdf?article_uuid=1a9460cc-c961-4aac-8e9f-4dc275ed723b" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11286.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Beales I. Recent advances in the management of peptic ulcer bleeding [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1763 (<a href="https://doi.org/10.12688/f1000research.11286.1" target=_blank>https://doi.org/10.12688/f1000research.11286.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11286 id=mobile-track-article-signin-11286 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11286?target=/articles/6-1763.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12175 /> <input name=articleId type=hidden value=11286 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>David M Jensen</strong>, David Geffen School of Medicine at UCLA, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Grigorios I Leontiadis</strong>, Department of Medicine, Division of Gastroenterology, McMaster University, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 27 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1763.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1763.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=26516-26428></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=26515-26429></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1763/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>27 Sep 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>David M Jensen</strong>, David Geffen School of Medicine at UCLA, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Grigorios I Leontiadis</strong>, Department of Medicine, Division of Gastroenterology, McMaster University, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1763.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1763/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in the management of peptic...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1763/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1763/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1763/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Beales I');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1763/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1763",
            templates : {
                twitter : "Recent advances in the management of peptic ulcer bleeding. Beales I, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1763/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in the management of peptic ulcer bleeding", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in the management of peptic ulcer bleeding", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11286/12175")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12175");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "26428": 0,
                           "26429": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "b0f5ee51-69bd-41c6-953d-7a2f360e38d5";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1763.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1763.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1763.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1763.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1763.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>